Drugs
MDMA for PTSD just crushed its phase 3 trial
Results from the first phase 3 trial of using MDMA for PTSD along with talk therapy found the drug to be effective.
Phase 2 trial finds psychedelic works as well as common drug
A small study has provided evidence of psilocybin for depression working as well as a popular SSRI.
Fireside Project is a support line for your bad trip
Fireside Project is a nonprofit that is providing a support line for your challenging psychedelic experiences — read: bad trip.
"Complex" and "exciting": Researchers study the use of CBD for pain
In a small study, researchers at Syracuse found that both thinking you’re getting CBD for pain and the drug increase pain tolerance.
How long are you too high to drive? The science is fuzzy.
Some drug driving laws outlaw any amount of THC. To create better laws, researchers are trying to find out how long cannabis intoxication itself lasts.
Can CBD be the next superbug slayer?
In the search for new weapons against superbugs, CBD and antibiotics in combination, as well as CBD alone, may prove to be promising candidates.
NYU is launching a center for psychedelic medicine
NYU’s Center for Psychedelic Medicine will serve as the nexus for the school’s psychedelic research, as well as provide training to budding researchers.
First-of-its-kind pilot study uses MDMA for alcohol addiction
A small, first-of-its-kind study has piloted the use of MDMA for alcohol addiction therapy.
Oral ketamine treatment reduced suicidal thoughts: Pilot study
A new, small study in Australia suggests that oral ketamine treatment may help treat suicidal thoughts.
Friendly little mice are helping us understand the effects of LSD
Researchers at McGill have discovered the mechanisms behind the sociable effects of LSD in mice.